Magic mushroom compound may shield cancer patients from chemo nerve pain
NCT ID NCT07227909
First seen Nov 17, 2025 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study tests whether psilocybin, a compound found in certain mushrooms, can prevent or lessen nerve damage caused by chemotherapy in people with breast, colorectal, or head and neck cancer. About 83 participants will receive either psilocybin, a placebo, or standard supportive care before starting chemo. The goal is to see if psilocybin can safely reduce the severity of chemotherapy-induced peripheral neuropathy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.